Early Biomarkers as Predictors of Nephrology Trial Trajectory
Chronic kidney disease (CKD) and other nephrology conditions are a major global health challenge. With rising prevalence and persistent unmet …
Post
-
-
US launches Operation Trailblazer to strengthen clinical trials
The US Department of Health and Human Services (HHS) has announced a coordinated department-wide effort to strengthen America’s leadership in …
-
From collection to confidence: why clinical trial data reliability starts early
Every sponsor decision, from dose selection to portfolio prioritisation, depends on whether the evidence generated in a trial is based …
-
How real-world evidence can directly support innovation
For decades, randomised controlled trials (RCTs) have been considered the gold standard of clinical research. But as healthcare data becomes …
-
Risk of death from cervical cancer is now almost zero with HPV vaccine
Cervical cancer can cause death but can be prevented with the human papillomavirus (HPV) vaccine. A recent study in England …
-
Analysts point to Definium psychedelic’s MDD efficacy on Phase III success
Following the first late-stage win in a Phase III programme evaluating Definium Therapeutics’ lysergic acid diethylamide (LSD)-based psychedelic in major …
-
MSD’s anti-TL1A mAb from $10.8bn acquisition wins in Phase III trial
MSD’s investigational humanised monoclonal antibody targeting tumour necrosis factor-like cytokine 1A (TL1A), which it acquired during a $10.8bn buyout of …
-
GondolaBio reports positive data from Phase IIa trial of PORT-77
GondolaBio has reported positive results from its Phase IIa GATEWAY study of PORT-77, an investigational oral ABCG2 inhibitor, which aims …
-
Medidata establishes Academic Site Advisory Board for clinical trials
Dassault Systèmes brand Medidata has announced the formation of its Academic Site Advisory Board to address the distinct operational and …
-
UK MHRA sets path for puberty blocker trial to continue
The Medicines and Healthcare products Regulatory Agency (MHRA) has cleared an investigator-led trial investigating puberty blockers in children and young people …
-
Kither Biotech concludes Phase I study of KIT2014
Kither Biotech has completed its Phase I clinical trial assessing KIT2014, an inhaled peptide therapy designed for the treatment of …
-
Post-marketing oncology studies: Enabling faster recruitment and lower costs
Post-marketing approval studies in clinical research for cancer typically suffer from poor engagement and protracted timelines – driving up costs …
-
First participant receives Evategrel in CureGene’s trial
CureGene Pharmaceutical has dosed the first participant in its pivotal clinical trial of Evategrel (CG-0255), a next-generation antiplatelet therapy, in …
-
Congressman proposes draft legislation to accelerate US clinical trials
A draft legislation aimed at accelerating drug discovery and clinical trials has been proposed in the US. Democratic Congressman Jake Auchincloss, …
-
Eye-opening study highlights connection between HPV and uveitis
Uveitis is the leading cause of preventable blindness in adults aged 20–60 years, and while some details are known about …
